- Home
- ARVN vs RNST Comparison
ARVN vs RNST Comparison
Compare ARVN & RNST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARVN
- RNST
- Stock Information
- Founded
- ARVN 2015
- RNST 1904
- Country
- ARVN United States
- RNST United States
- Employees
- ARVN N/A
- RNST N/A
- Industry
- ARVN Biotechnology: Pharmaceutical Preparations
- RNST Major Banks
- Sector
- ARVN Health Care
- RNST Finance
- Exchange
- ARVN Nasdaq
- RNST Nasdaq
- Market Cap
- ARVN 1.8B
- RNST 1.8B
- IPO Year
- ARVN 2018
- RNST N/A
- Fundamental
- Price
- ARVN $18.48
- RNST $35.49
- Analyst Decision
- ARVN Strong Buy
- RNST Buy
- Analyst Count
- ARVN 13
- RNST 5
- Target Price
- ARVN $63.00
- RNST $39.50
- AVG Volume (30 Days)
- ARVN 967.8K
- RNST 570.7K
- Earning Date
- ARVN 10-30-2024
- RNST 01-21-2025
- Dividend Yield
- ARVN N/A
- RNST 2.49%
- EPS Growth
- ARVN N/A
- RNST 6.89
- EPS
- ARVN N/A
- RNST 3.09
- Revenue
- ARVN $161,100,000.00
- RNST $685,874,000.00
- Revenue This Year
- ARVN $237.44
- RNST N/A
- Revenue Next Year
- ARVN N/A
- RNST $36.82
- P/E Ratio
- ARVN N/A
- RNST $11.45
- Revenue Growth
- ARVN 1.07
- RNST 8.24
- 52 Week Low
- ARVN $17.37
- RNST $27.98
- 52 Week High
- ARVN $53.08
- RNST $39.47
- Technical
- Relative Strength Index (RSI)
- ARVN 32.78
- RNST 41.02
- Support Level
- ARVN $17.37
- RNST $36.12
- Resistance Level
- ARVN $19.21
- RNST $37.72
- Average True Range (ATR)
- ARVN 1.64
- RNST 1.05
- MACD
- ARVN -0.59
- RNST -0.38
- Stochastic Oscillator
- ARVN 11.80
- RNST 26.00
About ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
About RNST Renasant Corporation
Renasant Corp operates as a holding company for Renasant Bank, a Mississippi banking corporation, and its subsidiary, Renasant Insurance, Inc. It has three reportable segments: community banks, insurance, and wealth management. With its community banks segment, the company provides a range of financial services to individuals and small businesses. Its insurance segment is an insurance agency providing commercial and personal insurance through third-party carriers. The wealth management segment provides a range of services including money management and retirement planning. The majority of the company's revenue is driven by lending activities in its community banks segment. Renasant Corporation operates in the southern United States.